NCT06155539View on ClinicalTrials.gov

A Study of Blood Metabolic Markers in Patients With Type 2 Diabetes Mellitus of Different Stages

Not yet recruitingOBSERVATIONAL
Enrollment

105

Participants

Timeline

Start Date

January 1, 2024

Primary Completion Date

May 31, 2025

Study Completion Date

December 31, 2025

Conditions
Diabetes Mellitus, Type 2
Interventions
OTHER

No intervention

No intervention

Trial Locations (1)

250014

Peng Wu, Jinan

All Listed Sponsors
lead

Peng Wu

OTHER

NCT06155539 - A Study of Blood Metabolic Markers in Patients With Type 2 Diabetes Mellitus of Different Stages | Biotech Hunter | Biotech Hunter